How a $200 Million Crisis Built America's Most Proven 15% Fixed Return

After the recovery, word spread about what we could do with receivables. A hedge fund came to us and hired us to collect their personal injury receivables: doctors who had treated car accident and workplace injury patients whose cases were tied up in legal settlements that could drag on for years.

We did the work. And we were good at it. Naturally we wondered...

If they're paying us this much to collect for them, what are they actually making?

But it wasn't just the margins that caught our attention. It was the structure of the asset itself. A personal injury medical receivable isn't a speculation. It's a legal obligation. When a patient is treated under a Letter of Protection or a Letter of Claim, the insurance carrier is contractually bound to pay. These aren't hopeful invoices. They're enforceable debts backed by some of the most heavily capitalized institutions in the country.

We realized that with the right underwriting (strategic selection of which receivables to acquire, disciplined collateral ratios, and full control of the billing and collections process) we could engineer returns that were practically inevitable. Not speculative. Not market-dependent. Structurally protected.

And the market was enormous. Personal injury medical receivables represent a $160 billion annual flow. We weren't looking at a niche. We were looking at a massive, recurring asset class that almost nobody in finance had figured out how to monetize at scale.

We knew we were sitting on gold.

In 2015 we launched our first fund. Eleven investors. One million dollars. The returns were strong enough that every single one of those original investors is still with us today, now across multiple funds on our platform.

That first fund proved the thesis. So we took what we learned and built something even more deliberate: a fixed return fund. One number. No variables. No surprises. 15% per year, paid every quarter, backed by real collateral.

We have kept that promise every single quarter since.

Over the next decade we built something bigger than a fund. We built a full specialty finance platform, purpose-built for personal injury medical receivables from the ground up. We advance capital directly to providers. They get cash now instead of waiting years. We hold their receivables as collateral at roughly a 4:1 ratio and take over billing and collections entirely. When the insurance settles and our financing is repaid, the remaining balance goes back to the doctor.

Ten years of refining every piece of this. Every early mistake learned from. Every process tightened. What started as eleven investors and a million dollars is now a platform that has been stress tested through market crashes, a global pandemic, and every economic curveball of the last decade, and has never missed a single payment.

That's not a model anymore. That's a machine.